DORILLO, ERICA
 Distribuzione geografica
Continente #
NA - Nord America 505
EU - Europa 413
AS - Asia 213
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.136
Nazione #
US - Stati Uniti d'America 504
IT - Italia 162
IE - Irlanda 128
SG - Singapore 90
HK - Hong Kong 57
CN - Cina 31
RO - Romania 29
VN - Vietnam 24
DE - Germania 22
FI - Finlandia 15
SE - Svezia 14
RU - Federazione Russa 10
UA - Ucraina 9
CZ - Repubblica Ceca 8
KR - Corea 7
AT - Austria 4
BE - Belgio 4
CI - Costa d'Avorio 4
FR - Francia 4
CH - Svizzera 2
NL - Olanda 2
CA - Canada 1
EU - Europa 1
IN - India 1
JP - Giappone 1
KH - Cambogia 1
UZ - Uzbekistan 1
Totale 1.136
Città #
Chandler 147
Dublin 128
Perugia 72
Singapore 71
Hong Kong 57
San Mateo 51
Boardman 37
Bucharest 28
Dong Ket 24
Santa Clara 24
Altamura 19
Medford 15
Wilmington 14
Helsinki 13
Princeton 13
Lawrence 12
New York 12
Andover 10
Assisi 9
Beijing 7
Munich 7
Seoul 7
Brno 5
Dallas 5
Falls Church 5
San Paolo di Civitate 5
Abidjan 4
Bastia 4
Brussels 4
Collazzone 4
Dearborn 4
Foligno 4
Los Angeles 4
Rome 4
Vienna 4
Ashburn 3
Guangzhou 3
Olomouc 3
Redwood City 3
Amsterdam 2
Ancona 2
Bologna 2
Frankfurt Am Main 2
Macerata 2
Melissa 2
Moscow 2
Norwalk 2
Redmond 2
West Jordan 2
Ann Arbor 1
Baotou 1
Bhubaneswar 1
Cambridge 1
Civitanova Marche 1
Fairfield 1
Fremont 1
Hanover 1
Jinan 1
Lappeenranta 1
Montréal 1
Nanjing 1
Paris 1
Quattro Castella 1
Sector 6 1
Spello 1
Tokyo 1
Totale 882
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 131
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 80
NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status 73
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 71
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 71
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 69
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 69
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications 67
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 62
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 61
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 59
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 57
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 44
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 40
null 37
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 37
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 32
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 30
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 26
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL 25
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 22
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia 18
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential 17
Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies 6
Totale 1.204
Categoria #
all - tutte 6.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202041 0 0 0 0 0 4 4 2 4 25 2 0
2020/202160 0 0 0 0 19 2 2 2 7 0 0 28
2021/2022240 12 49 3 2 9 4 3 34 11 31 37 45
2022/2023408 14 65 0 57 44 27 11 21 146 1 15 7
2023/2024231 8 25 11 15 2 13 69 1 11 10 30 36
2024/2025157 26 44 19 27 41 0 0 0 0 0 0 0
Totale 1.204